Target setup
Capture molecule, host, feedstock, production mode, business objective, constraints, and assay readiness.
Stra-Forge® helps synthetic biology companies turn scattered literature, pathway evidence, enzyme data, host constraints, and early economics into traceable design decisions.
Instead of behaving like a general chatbot, Stra-Forge® follows a reproducible decision pipeline: define the target, gather evidence, reconstruct biology, screen feasibility, rank designs, and learn from outcomes.
Capture molecule, host, feedstock, production mode, business objective, constraints, and assay readiness.
Search exact and related compounds across literature, patents, databases, and internal reports.
Normalize molecules, enzymes, hosts, units, and reported titer / rate / yield into comparable evidence.
Reconstruct candidate routes, required heterologous steps, cofactors, bottlenecks, and host gaps.
Connect strain metrics to product category, downstream difficulty, and early techno-economic pressure.
Recommend safest first pass, highest upside, and most informative experiment set with evidence traceability.
Select a target molecule and host assumption. The demo shows the intended customer workflow: evidence summary, pathway map, commercial screen, and ranked design recommendation. Outputs are illustrative and not wet-lab protocols.
High-value polyphenol / nutraceutical ingredient.
| Evidence type | Signal | Decision use |
|---|
The demo now reflects the practical build sequence: evidence engine first, then recommendation engine, then feedback learning.
Collect molecule, host, feedstock, production mode, lab constraints, commercial priority, and project objective.
Show structured studies, enzyme candidates, reported metrics, optimization strategies, and confidence tags.
Visualize precursor flow, heterologous steps, host-native reactions, cofactor needs, and likely bottlenecks.
Rank safest first-pass, highest-upside, and most informative build strategies with transparent scoring.
Generate investor, management, or R&D-facing feasibility memos with assumptions and traceable evidence.
Upload experimental outcomes to update confidence in pathways, enzymes, host compatibility, and design rules.
The first commercial MVP should not hide behind a black box. Stra-Forge® can start with a traceable scoring model, then improve as real outcomes flow back into the platform.
The demo is structured around a realistic implementation sequence: narrow scope, build golden reports, create evidence infrastructure, and expand into a closed-loop platform.
Pick one molecule class and two hosts. Manually produce 3 high-quality feasibility reports to define the ideal product output.
Build literature ingestion, structured extraction, entity normalization, evidence tables, and human curation workflow.
Add pathway reconstruction, bottleneck templates, scoring logic, commercial screen, and report export.
Ingest experimental outcomes to update enzyme confidence, host compatibility, bottleneck prediction, and ranking weights.
Stra-Forge® should be biosecurity-aware from day one. The product experience can be useful without generating risky implementation details.
Every recommendation should carry evidence references, confidence levels, assumptions, and reviewer status. The goal is decision-grade evidence, not unverifiable AI answers.
The platform should avoid pathogen enhancement, toxin production, evasion mechanisms, and direct DNA-ordering outputs. Sensitive cases should trigger human review.
Enterprise data should remain private by default, with tenant-level isolation and explicit permission before any data is used for model or benchmark improvement.
The first version should include expert review for extracted evidence and high-impact recommendations. This builds trust and creates proprietary structured data.
The right first customer motion is a paid feasibility or strain-design project: one target, one host assumption, one evidence-backed recommendation memo, and a clear path toward a recurring platform workflow.